---  
layout: startup_page  
title: "Remix Therapeutics"  
id: "remixtx.com"  
permalink: "/remixtherapeuticsremixtx.com01032024/"  
website: "https://www.remixtx.com"  
funding_round: ""  
funding_amount: "$60M"  
investors: "The Column Group, Atlas Venture, Foresite Capital, Alexandria Venture Investments, Arch Venture Partners, Casdin Capital, Surveyor (a Citadel company), WTT Investment, Willett Advisors"  
about: "Remix Therapeutics is a clinical-stage biotechnology company developing small molecule therapies to modulate RNA processing and address the underlying drivers of disease. Its REMaster technology platform identifies and targets key RNA processing steps to modulate gene expression, offering a novel approach to treating diseases. The company's lead candidate, REM-422, is expected to enter Phase 1 clinical studies in 2024."  
markets: "Biotechnology, RNA Processing, Therapeutics, Health Care, Medical, Drug Discovery, Life Sciences, Oncology"  
hq: "Watertown, Massachusetts, United States"  
founded_year: "2019"  
linkedin: "https://www.linkedin.com/company/remix-therapeutics"  
twitter: "https://twitter.com/remixthera"  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/remix-therapeutics"  
pitchbook: "https://pitchbook.com/profiles/company/442833-04"  

date_display: "03-Jan-2024"  
date: "2024-01-03"

# SEO Optimization  
meta_title: "Remix Therapeutics -  Funding ($60M)"  
meta_description: "Remix Therapeutics, Remix Therapeutics is a clinical-stage biotechnology company developing small molecule therapies to modulate RNA processing and address the underlying..."  
meta_keywords: "Remix Therapeutics, Biotechnology, RNA Processing, Therapeutics, Health Care, Medical, Drug Discovery, Life Sciences, Oncology,  funding"  
canonical_url: "https://startup.projectstartups.com/remixtherapeuticsremixtx.com01032024/"  
---